JURISDICTION : STATE ADMINISTRATIVE TRIBUNAL
ACT: HEALTH PRACTITIONER REGULATION NATIONAL LAW (WA) ACT 2010 (WA)
CITATION: PHARMACY BOARD OF AUSTRALIA and HEGDE [2023] WASAT 109
MEMBER: JUDGE K GLANCY, DEPUTY PRESIDENT
MR D AITKEN, SENIOR MEMBER
MS E PERRELLA, SESSIONAL MEMBER
HEARD: 18 SEPTEMBER 2023
DELIVERED : 13 NOVEMBER 2023
FILE NO/S: VR 96 of 2017
PHARMACY BOARD OF AUSTRALIA
Applicant
AND
CHETAN ANANT HEGDE
Respondent
Catchwords:
Vocational regulation - Pharmacist - Disciplinary proceedings - Professional misconduct - Factors relevant to penalty - Dispensing of anabolic androgenic steroids - Registration suspended for a period of two months
Legislation:
Health Practitioner Regulation National Law (WA) Act 2010 (WA), s 3(2)(a), s 4, s 5, s 6, s 196, s 196(1)(b)(iii), s 196(2), s 196(4)
Legal Profession Act 2008 (WA)
Result:
Practitioner reprimanded
Practitioner's registration suspended for a period of two months
Practitioner fined amount of $10,000
Category: B
Representation:
Counsel:
| Applicant | : | J McKenzie & E Caddy |
| Respondent | : | A P Hershowitz |
Solicitors:
| Applicant | : | Minter Ellison |
| Respondent | : | Meridian Lawyers (Perth) |
Case(s) referred to in decision(s):
Chen v Health Care Complaints Commission (2017) 95 NSWLR 334
Hamilton v Pharmacy Board of Australia [No 2] [2022] WASCA 155
Hegde v Pharmacy Board of Australia [2020] WASC 383
Hegde v Pharmacy Board of Australia [No 2] [2020] WASC 384
Khosa v Legal Professional Complaints Committee [2017] WASCA 192
Legal Profession Complaints Committee v Segler [2014] WASC 159
Medical Board of Australia and Singh [2017] WASAT 33 (S)
Nadkarni v Medical Board of Australia [2022] WASCA 109
Panegyres v Medical Board of Australia [2020] WASCA 58
Pharmacy Board of Australia and Hamilton [2018] WASAT 95
Pharmacy Board of Australia and Nyoni [2018] WASAT 134 (S)
Singh v Medical Board of Australia [2019] WASCA 51
Young v Legal Profession Complaints Committee [2022] WASCA 52
REASONS FOR DECISION OF THE TRIBUNAL:
Introduction
On 7 August 2020, Mr Chetan Hegde (variously the Respondent or Mr Hegde), a pharmacist, was found guilty of professional misconduct as defined in s 5 of the Health Practitioner Regulation National Law (WA) Act 2010 (WA) (National Law) by a differently constituted Tribunal which also imposed a penalty pursuant to s 196(2) of the National Law.[1]
[1] Order 1 of the Orders made on 7 August 2020.
That finding of professional misconduct was made after the parties had filed an Agreed Statement of Facts and Findings on 1 July 2019 (Agreed Facts and Findings) that addressed the Respondent's liability for his conduct.[2]
[2] The Agreed Facts and Findings were Annexure A to orders made on 3 July 2019.
Following an appeal to the Supreme Court,[3] the orders relating to penalty were set aside and an order was made that the question of penalty be remitted for hearing and determination according to law by the Tribunal differently constituted.[4]
[3] Hegde v Pharmacy Board of Australia [2020] WASC 383 (Hegde Appeal Decision).
[4] Supreme Court Orders dated 23 October 2020.
This matter concerns the penalty to be…
Keep reading for free
Create a free CaseChat account to read PHARMACY BOARD OF AUSTRALIA and HEGDE and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2023] WASAT 109
- Decision Date
CaseChat Overview and Summary
The legal issues before the Tribunal centred on the appropriate penalty for Mr Hegde's misconduct, which included dispensing anabolic androgenic steroids in quantities and combinations that were not necessary for therapeutic purposes, failing to provide adequate clinical notes, and dispensing repeat authorisations and multiple prescriptions in close proximity. The Tribunal needed to balance the seriousness of the misconduct with the unique circumstances of the case, including the implications of the Court of Appeal's decision in Hamilton v Pharmacy Board of Australia [No 2]. The Tribunal also had to consider the potential adverse effects of anabolic androgenic steroids and the financial incentives for practitioners involved in their inappropriate dispensing.
In reaching its decision, the Tribunal considered the Agreed Facts and Findings, expert reports, witness statements, character references, and submissions from both the Pharmacy Board of Australia and Mr Hegde. The Tribunal noted that while the professional misconduct was serious, the unique circumstances of this case warranted a different approach to penalty. The Tribunal accepted that the potential side effects of anabolic androgenic steroids and the financial rewards for their inappropriate dispensing were critical factors in determining the penalty. The Tribunal also considered the implications of the Court of Appeal's decision in Hamilton, which had implications for the penalty to be imposed in this case. Ultimately, the Tribunal decided that a reprimand, a suspension of Mr Hegde's registration for two months, and a fine of $10,000 were appropriate penalties given the circumstances.
The Tribunal ordered that Mr Hegde be reprimanded, his registration suspended for a period of two months, and that he pay a fine of $10,000. These penalties reflect the seriousness of the professional misconduct while also taking into account the unique circumstances of this case. The Tribunal's decision underscores the importance of considering the full context of each case when determining appropriate penalties for professional misconduct.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi